Streetbeat News

Products Services

SNY

Sanofi's Sarclisa has been accepted for FDA priority review for treating transplant-ineligible newly diagnosed multiple myeloma, based on positive results from the IMROZ phase 3 study. If approved, it would be the first anti-CD38 therapy in combination with standard-of-care treatment for this patient group.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:13 am

SATS

Hughes Network Systems, a subsidiary of EchoStar (NASDAQ:SATS), introduced its Low Earth Orbit (LEO) Electronically Steerable Antenna (ESA) for In-Flight Entertainment & Connectivity (IFEC) at the Aircraft Interiors Expo (AIX). This new technology aims to revolutionize aviation connectivity with high-speed, low-latency internet.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:12 am

RTX

RTX's Collins Aerospace and Panasonic Avionics have launched MAYA, a next-generation business class suite, at the 2024 Aircraft Interiors Expo in Hamburg, Germany. This new product aims to redefine comfort, passenger immersion, accessibility, and sustainability in air travel.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:11 am

NDAQ

Nasdaq (NASDAQ:NDAQ) and FIA Tech have announced a partnership to enhance post-trade data processing in the exchange-traded derivative market. Nasdaq will integrate its Real-Time Clearing platform into FIA Tech's Trade Data Network.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:08 am

BTCUSD

ETHUSD

Former SEC Chair Jay Clayton predicts the inevitable trading of Ethereum spot ETFs in the U.S., following the SEC's recent approval. This move is expected to boost Ethereum's mainstream adoption, similar to Bitcoin's post-ETF success.

Portfolio Pulse from Aniket Verma

May 28, 2024 | 7:07 am

GOGO

Gogo Business Aviation (NASDAQ:GOGO) has partnered with ALAMO Engineering GmbH to develop a European Supplemental Type Certificate (STC) for the Gogo Galileo HDX antenna for Cessna Citation Latitude midsize jets.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:06 am

AZN

DSNKY

Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan shows improved survival rates versus chemotherapy in advanced nonsquamous non-small cell lung cancer patients in the TROPION-Lung01 Phase 3 trial. While the survival results favored the drug, they did not reach statistical significance. The trial had previously met the dual primary endpoint of progression-free survival. These results support ongoing regulatory reviews globally, including in the U.S. and EU.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 7:03 am

AAPL

Apple Inc. (NASDAQ:AAPL) has launched its first OLED-screen iPad Pro, targeting over 9 million shipments this year. This comes amid a decline in the overall IT device market. The new iPad Pro features OLED panels and the M4 chip designed for AI. LG Display and Samsung Display are key suppliers, aiming to ship 5 million and over 4 million OLED units respectively.

Portfolio Pulse from Ananya Gairola

May 28, 2024 | 6:58 am

ATRO

Astronics' EmPower UltraLite G2 USB Power System will be installed on 650 aircraft by the end of the year. The company has delivered 350 shipsets and plans to deliver 300 more in 2024. The system supports airlines' efforts to reduce carbon emissions by weighing 30% to 40% less.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 6:44 am

LLY

Eli Lilly's CEO, David Ricks, expressed confidence in meeting Bank of America's $60 billion revenue projection from new drug launches by 2030. The company is focusing on proving the efficacy of its drugs for weight loss and obesity-driven diseases. Recent strategic investments, including a $5.3 billion manufacturing investment in Indiana, bolster this confidence.

Portfolio Pulse from Benzinga Neuro

May 28, 2024 | 6:38 am